PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate CMPR Q1 2026 Earnings Stellar EPS Beat Drives Investor Optimism Despite Stock Pullback US GDP Growth for Q1 2026 Revised Lower to 16 as Corporate Profits Slow